Menu
Science and research

Professional Publications

Author
Title
Year of publication

Publications (3451)

[81]

Moravcová, J.; Nádvorníková, S.; Lukášová, M.; Klamová, H.

Polymerase chain reaction analyses should be used as a basis for clinical decision making in patients with chronic myelogenous leukemia

[year of publication 2006, impact factor 8.782]

[82]

Hernández-Boluda, J.C.; Pereira, A.; Kröger, N.; Beelen, D.; Robin, M.; Bornhäuser, M.; Angelucci, E.; Vítek, A.; et al.

Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation

[year of publication 2020, impact factor 8.665 ]

[83]

Von Lilienfeld-Toal, M.; Vehreschild, J.J.; Cornely, O.; Pagano, L.; Compagno, F.; Hirsch, H.H.; Pagliuca, A.; Akan, H.; Lagrou, K.; Hoenigl, M.; Klimko, N.; Verweij, P.; Duarte, R.; Zimmerli, S.; Bretagne, S.; Racil, Z.

Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases

[year of publication 2020, impact factor 8.665 ]

[84]

Machova Polakova, K.; Zizkova, H.; Zuna, J.; Motlova, E.; Hovorkova, L.; Gottschalk, A.; Glauche, I.; Koblihova, J.; Pecherkova, P.; Klamova, H.; Stastna Markova, M.; Srbova, D.; Benesova, A.; Polivkova, V.; et al.

Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission

[year of publication 2020, impact factor 8.665 ]

[85]

Lorentino, F.; Labopin, M.; Ciceri, F.; Vago, L.; Fleischhauer, K.; Afanasyev, B.; Kröger, N.; Cornelissen, J.J.; Lovira, M.; Meijer, E.; Vitek, A.; et al.

Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia

[year of publication 2020, impact factor 8.665 ]

[86]

Schetelig, J.; de Wreede, L.C.; van Gelder, M.; Koster, L.; Finke, J.; Niederwieser, D.; Beelen, D.; Mufti, G.J.; Platzbecker, U.; Ganser, A.; Heidenreich, S.; Maertens, J.; Socié, G.; Brecht, A.; Stelljes, M.; Kobbe, G.; Volin, L.; Nagler, A.; Vitek, A.; et al.

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

[year of publication 2019, impact factor 8.665 ]

[87]

Schwarz, J.; Penka, M.; Indrák, K.; Pospíšilová, D.; Pytlík, R.; Dulíček, P.; Doubek, M.; Křen, L.; Campr, V.

The WHO 2008 classification of Ph-myeloproliferative disorders : statement of the Czech MPD Working Group

[year of publication 2008, impact factor 8.634]

[88]

De Boer, C.J.; Schuuring, E.; Dreef, E.; Peters, G.; Bartek, J.; Kluin, P.M.; Van Krieken, J.H.

Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma

[year of publication 2006, impact factor 8.569]

[89]

Jarolim, P.; Rubin, H.L.; Brabec, V.; Palek, J.

Comparison of the ankyrin (AC)n microsatellites in genomic DNA and mRNA reveals absence of one ankyrin mRNA allele in 20% of patients with hereditary spherocytosis

[year of publication 2006, impact factor 8.569]

[90]

Jarolim, P.; Rubin, H.L.; Brabec, V.; Chrobak, L.; Zolotarev, A.S.; Alper, S.L.; Brugnara, C.; Wichterle, H.; Palek, J.

Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis

[year of publication 2006, impact factor 8.569]

[91]

Jarolim, P.; Rubin, H.L.; Liu, S.C.; Cho, M.R.; Brabec, V.; Derick, L.H.; Yi, S.J.; Saad, S.T.; Alper, S.; Brugnara, C.

Duplication of 10 nucleotides in the erythroid band 3 (Ae1) gene in a kindred with hereditary spherocytosis and band 3 protein deficiency (band 3PRAGUE)

[year of publication 2006, impact factor 8.467]

[92]

Jarolim, P.; Rubin, H.L.; Brabec, V.; Palek, J.

A nonsense mutation 1669Glu->Ter within the regulatory domain of human erythroid ankyrin leads to a selective deficiency of the major ankyrin isoform (band 2.1) and a phenotype of autosomal dominant hereditary spherocytosis

[year of publication 2006, impact factor 8.467]

[93]

Stopka, T.; Zivny, J.H.; Stopkova, P.; Prchal, J.F.; Prchal, J.T.

Human hematopoietic progenitors express erythropoietin

[year of publication 2006, impact factor 8.372]

[94]

Jarolim, P.; Rubin, H.L.; Zakova, D.; Storry, J.; Reid, M.

Characterization of seven low incidence blood group antigens carried by erythrocyte band 3 proteins

[year of publication 2006, impact factor 8.372]

[95]

Ullmannova-Benson, V.; Guan, M.; Zhou, X.; Tripathi, V.; Yang, X.-Y.; Zimonjic, D.B.; Popescu, N.C.

DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway

[year of publication 2009, impact factor 8.296]

[96]

Brodská, B.; Otevřelová, P.; Kuželová, K.

Correlation of PD-L1 surface expression on leukemia cells with the ratio of PD-L1 mRNA variants and with electrophoretic mobility

[year of publication 2016, impact factor 8.284 ]

[97]

Liu, S.C.; Jarolim, P.; Rubin, H.L.; Palek, J.; Amato, D.; Hassan, K.; Zaik, M.; Sapak, P.

The homozygous state for the band 3 protein mutation in southeast Asian ovalocytosis may be lethal

[year of publication 2006, impact factor 8.279]

[98]

Lenzner, C.; Nürnberg, P.; Thiele, B.J.; Reis, A.; Brabec, V.; Sakalová, A.; Jacobasch, G.

Mutations in the pyruvate kinase L gene in patients with hereditary hemolytic anemia

[year of publication 2006, impact factor 8.279]

[99]

Nagarajan, L.; Zavadil, J.; Claxton, D.; Lu, X.; Fairman, J.; Warrington, J.A.; Wasmuth, J.J.; Chinault, A.C.; Sever, C.E.; Slovak, M.L.; Willman, C.L.; Deisseroth, A.B.

Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to Egr-1 in patients with 5q- chromosome

[year of publication 2006, impact factor 8.279]

[100]

Lukas, J.; Aagaard, L.; Strauss, M.; Bartek, J.

Oncogenic aberrations of p16(INK4/CDKN2) and cyclin D1 cooperate to deregulate G(1) control

[year of publication 2006, impact factor 8.206]


Quick contact

Head of Science and Research Division
Tel:+420 221 977 208

Deputy head of Science and Research Division
Tel:+420 221 977 269
Tel:+420 221 977 364

Secretary
Tel:+420 221 977 247


Opening hours

Ambulance
Mo – Fr: 7:00–18:00
Weekends: 9:00–13:00

Donors
Mo – Fr: 7:00–10:30

Visitors
Inpatient department
Mo – Fr: 13:00–18:00

ICU and Transplant unit
Mo – Fr: 14:00–17:00

How to find us

map

Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here